Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Novo Nordisk, which became the most valuable company in Europe last year due to the blockbuster success of its weight loss drugs, on Thursday beat first-quarter profit expectations as demand for those medications boomed.